E
Aion Therapeutic Inc. ANTCF
$0.006 -$0.006-50.00%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
E
Sell 8/22/2023Downgrade
Aion Therapeutic Inc. (ANTCF) was downgraded to E+ from D- on 8/22/2023 due to a decline in the volatility index.
D
Sell 8/2/2023Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to D- from E+ on 8/2/2023 due to a noticeable increase in the volatility index and total return index.
E
Sell 6/14/2023Downgrade
Aion Therapeutic Inc. (ANTCF) was downgraded to E+ from D- on 6/14/2023 due to a decline in the volatility index.
D
Sell 5/30/2023Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to D- from E+ on 5/30/2023 due to a noticeable increase in the solvency index, volatility index and total return index.
E
Sell 1/4/2023Downgrade
Aion Therapeutic Inc. (ANTCF) was downgraded to E+ from D- on 1/4/2023 due to a noticeable decline in the solvency index, total return index and volatility index. The quick ratio declined from 0.08 to 0.08.
D
Sell 11/7/2022Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to D- from E+ on 11/7/2022 due to a noticeable increase in the growth index, solvency index and valuation index. Operating cash flow increased 111.89% from -$77.4 to $9.2.
E
Sell 3/22/2022Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to E+ from E on 3/22/2022 due to an increase in the volatility index and total return index.
E
Sell 3/7/2022Downgrade
Aion Therapeutic Inc. (ANTCF) was downgraded to E from E+ on 3/7/2022 due to a decline in the volatility index.
E
Sell 2/11/2022Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to E+ from E on 2/11/2022 due to an increase in the volatility index and total return index.
E
Sell 1/27/2022Downgrade
Aion Therapeutic Inc. (ANTCF) was downgraded to E from E+ on 1/27/2022 due to a decline in the volatility index.
E
Sell 1/3/2022Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to E+ from E on 1/3/2022 due to an increase in the valuation index.
E
Sell 10/1/2021Upgraded
Aion Therapeutic Inc. (ANTCF) was upgraded to E from E- on 10/1/2021 due to an increase in the total return index, volatility index and valuation index.
E
Sell 7/16/2021None
Aion Therapeutic Inc. (ANTCF) was downgraded to E- from U on 07/16/2021.
Weiss Ratings